Ron Wyden

Pharma

Amgen is the latest drugmaker in Senate committee's tax probe

Amgen has paid an average effective tax rate of just 12% over the past four years, according to the chair of the U.S. Senate Committee on Finance.
Fraiser Kansteiner Aug 12, 2022 8:56am

Merck dodged billions in US taxes, Senate Democrats contend

Jul 28, 2022 7:01am

Senate uses AbbVie in push to roll back Trump-era tax measures

Jul 7, 2022 11:26am

How did Merck record an 11% tax rate last year?

Apr 5, 2022 10:33am

Califf wins over Senate in narrow vote

Feb 15, 2022 9:10am

As calls for pricing reform intensify, industry execs push back

Sep 8, 2021 11:23am